<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548687</url>
  </required_header>
  <id_info>
    <org_study_id>496</org_study_id>
    <nct_id>NCT04548687</nct_id>
  </id_info>
  <brief_title>a Randomized Clinical Trial Evaluating the Effectiveness of Carbon Dioxide Use in Cardiac Surgery</brief_title>
  <acronym>CAR-DRIVER</acronym>
  <official_title>Pilot Prospective Randomized Clinical Trial &quot;Insufflation of Carbon Dioxide During Minimally Invasive and Repeated Cardiac Surgery&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      study of the efficacy and safety of carbon dioxide in cardiac surgery: repeated or minimally&#xD;
      invasive&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      prospective randomized clinical single-center study of the efficacy and safety of using&#xD;
      carbon dioxide in deaeration of cardiac cavities during cardiac surgery (repeated&#xD;
      interventions and minimally invasive interventions)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2020</start_date>
  <completion_date type="Anticipated">June 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group 1: patients with planned minimally invasive or repeated cardiac surgery using standard methods of deaeration of cardiac cavities.&#xD;
Group 2: patients with planned minimally invasive or repeated cardiac surgery using standard methods of deaeration of cardiac cavities, supplemented with carbon dioxide insufflation during surgery</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>delirium: CAM-ICU, 3-D CAM</measure>
    <time_frame>7 days after surgery</time_frame>
    <description>positive test development of postoperative delirium: Richmond Agitation-Sedation Scale, Confusion Assessment Method-Intensive Care Unit (more than one error) - while in the intensive care unit; positive test the 3-Minute Diagnostic Interview for Confusion Assessment Method (CAM) defined delirium - while in the ward of the department: The CAM algorithm is considered positive if the following features are present: Feature 1) Acute onset or fluctuating course and Feature 2) Inattention and either Feature 3) Disorganized thinking or Feature 4) Altered level of consciousness.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>deaeration time</measure>
    <time_frame>intraoperatively</time_frame>
    <description>deaeration time according to transesophageal echocardiography data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neurocognitive dysfunction</measure>
    <time_frame>7 days after surgery</time_frame>
    <description>development of neurocognitive dysfunction: Montreal Cognitive Assessment - two days before surgery and 7 days after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Carbon Dioxide</condition>
  <arm_group>
    <arm_group_label>carbon dioxide insufflation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with planned minimally invasive or repeated cardiac surgery using standard methods of deaeration of cardiac cavities, supplemented with carbon dioxide insufflation during surgery + standard methods of deaeration of cardiac cavities</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no carbon dioxide</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>standard methods of deaeration of cardiac cavities: manual method, change in body position, through the cannula of the ascending aorta, through the drainage of the left ventricle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>carbon dioxide insufflation</intervention_name>
    <description>Carbon dioxide insufflation at a rate of 5 l / min. through the Redon drainage during cardiac surgery (minimally invasive or repeated) during cardiopulmonary bypass</description>
    <arm_group_label>carbon dioxide insufflation</arm_group_label>
    <other_name>carbon dioxide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No carbon dioxide insufflation</intervention_name>
    <description>standard methods of deaeration of cardiac cavities: manual method, change in body position, through the cannula of the ascending aorta, through the drainage of the left ventricle</description>
    <arm_group_label>no carbon dioxide</arm_group_label>
    <other_name>standard methods of deaeration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Planned cardiac surgery on the left heart with limited deaeration: Minimally invasive&#xD;
             approach (mininotomy, minimally invasive lateral thoracotomy); Re-intervention&#xD;
&#xD;
          -  Signed informed voluntary consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal to participate in any stage of the study&#xD;
&#xD;
          -  History of stroke, transient ischemic attack&#xD;
&#xD;
          -  Hemodynamically significant stenosis of the brachiocephalic arteries (more than 70%)&#xD;
&#xD;
          -  Swelling or thrombosis of the heart&#xD;
&#xD;
          -  LV dysfunction (EF less than 30%)&#xD;
&#xD;
          -  Atherosclerosis of the aorta (atheromatosis)&#xD;
&#xD;
          -  Surgical access conversion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander V. Bogachev-Prokophiev, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>E.Meshalkin National medical research center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander V. Bogachev-Prokophiev, MD, PhD</last_name>
    <phone>+73833476029</phone>
    <email>bogachev.prokophiev@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sergei A. Budagaev</last_name>
    <phone>+73833476029</phone>
    <email>ser.bud.med@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>&quot;E.Meshalkin National medical research center&quot; of the Ministry of Health of the Russian Federation</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander V. Bogachev-Prokophiev, MD, PhD</last_name>
      <phone>+73833476029</phone>
      <email>bogachev.prokophiev@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Sergei A. Budagaev</last_name>
      <phone>+73833476029</phone>
      <email>ser.bud.med@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>September 8, 2020</last_update_submitted>
  <last_update_submitted_qc>September 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>carbon dioxide</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>delirium</keyword>
  <keyword>minimally invasive intervention</keyword>
  <keyword>redo cardiac surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

